Dynavax Historical Financial Ratios
| DVAX Stock | USD 11.72 0.04 0.34% |
Dynavax Technologies is recently reporting on over 111 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as PTB Ratio of 4.48 or Days Sales Outstanding of 103 will help investors to properly organize and evaluate Dynavax Technologies financial condition quickly.
Dynavax |
About Dynavax Financial Ratios Analysis
Dynavax TechnologiesFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Dynavax Technologies investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Dynavax financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Dynavax Technologies history.
Dynavax Technologies Financial Ratios Chart
Dynavax Technologies financial ratios usually calculated using numerical values taken directly from Dynavax Technologies financial statements such as income statements or balance sheets. They help investors to obtain meaningful information about Dynavax Technologies. Most financial ratios help to conduct quantitative analysis to assess vital information about the company's valuation as well as profitability and liquidity indicators such as leverage, growth, profit margins, and different types of rates of return.
At this time, Dynavax Technologies' POCF Ratio is fairly stable compared to the past year. PFCF Ratio is likely to rise to 19.59 in 2024, whereas Price To Sales Ratio is likely to drop 7.36 in 2024. Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Dynavax Technologies stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Dynavax Technologies sales, a figure that is much harder to manipulate than other Dynavax Technologies multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company’s stock price to its revenues, calculated by dividing the company’s market cap by its total sales or revenue over a 12-month period.Invested Capital
Invested capital represents the total cash investment that shareholders and debt holders have contributed to Dynavax Technologies. There are two different methods for calculating Dynavax Technologies invested capital: operating approach and financing approach. Understanding Dynavax Technologies invested capital allows investors to calculate measures of performance such as return on invested capital or return on capital employed.Ev To Sales
The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.Most ratios from Dynavax Technologies' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Dynavax Technologies current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dynavax Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. For more information on how to buy Dynavax Stock please use our How to Invest in Dynavax Technologies guide.At this time, Dynavax Technologies' POCF Ratio is fairly stable compared to the past year. PFCF Ratio is likely to rise to 19.59 in 2024, whereas Price To Sales Ratio is likely to drop 7.36 in 2024.
| 2021 | 2022 | 2023 | 2024 (projected) | Payables Turnover | 66.76 | 81.64 | 9.56 | 10.55 | Days Of Inventory On Hand | 128.98 | 82.77 | 387.72 | 726.55 |
Dynavax Technologies fundamentals Correlations
Click cells to compare fundamentals
Dynavax Technologies Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Dynavax Technologies fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Price To Sales Ratio | 11.7 | 9.63 | 3.72 | 1.86 | 7.75 | 7.36 | |
| Ptb Ratio | 49.7 | 7.64 | 7.36 | 2.31 | 2.89 | 4.48 | |
| Days Sales Outstanding | 92.09 | 177.68 | 109.49 | 74.5 | 69.98 | 103.42 | |
| Book Value Per Share | 0.12 | 0.58 | 1.91 | 4.6 | 4.83 | 5.07 | |
| Free Cash Flow Yield | (0.37) | (0.23) | 0.2 | 0.0413 | 0.0536 | 0.0563 | |
| Invested Capital | 26.48 | 3.71 | 1.16 | 0.44 | 0.41 | 0.39 | |
| Operating Cash Flow Per Share | (1.68) | (0.92) | 2.89 | 0.5 | 0.78 | 0.82 | |
| Pb Ratio | 49.7 | 7.64 | 7.36 | 2.31 | 2.89 | 4.48 | |
| Ev To Sales | 16.71 | 13.62 | 3.32 | 1.94 | 8.21 | 7.8 | |
| Free Cash Flow Per Share | (2.09) | (1.03) | 2.8 | 0.44 | 0.75 | 0.79 | |
| Roic | (0.53) | (0.33) | 0.28 | 0.34 | (0.0616) | (0.0647) | |
| Inventory Turnover | 0.47 | 0.22 | 2.83 | 4.41 | 0.94 | 1.49 | |
| Net Income Per Share | (2.1) | (0.91) | 0.66 | 2.32 | (0.0496) | (0.0521) | |
| Days Of Inventory On Hand | 778.08 | 1.7K | 128.98 | 82.77 | 387.72 | 726.55 | |
| Payables Turnover | 2.09 | 4.2 | 66.76 | 81.64 | 9.56 | 10.55 | |
| Research And Ddevelopement To Revenue | 1.77 | 0.61 | 0.0733 | 0.0645 | 0.24 | 0.22 | |
| Capex To Revenue | (0.83) | (0.24) | (0.0216) | (0.009878) | (0.0177) | (0.0186) | |
| Cash Per Share | 2.1 | 1.64 | 4.7 | 4.94 | 5.77 | 5.48 | |
| Pocfratio | (3.4) | (4.86) | 4.88 | 21.44 | 17.9 | 18.79 | |
| Interest Coverage | (7.16) | (3.95) | 12.03 | 42.12 | (5.48) | (5.75) | |
| Pfcf Ratio | (2.73) | (4.34) | 5.02 | 24.2 | 18.66 | 19.59 | |
| Days Payables Outstanding | 174.66 | 86.91 | 5.47 | 4.47 | 38.16 | 36.25 | |
| Roe | (18.26) | (1.56) | 0.34 | 0.5 | (0.0103) | (0.0108) | |
| Ev To Operating Cash Flow | (4.85) | (6.87) | 4.34 | 22.34 | 18.96 | 19.9 | |
| Return On Tangible Assets | (0.55) | (0.26) | 0.074 | 0.3 | (0.006421) | (0.006742) | |
| Ev To Free Cash Flow | (3.91) | (6.14) | 4.47 | 25.21 | 19.76 | 20.75 | |
| Intangibles To Total Assets | 0.0164 | 0.006502 | 0.002045 | 0.002035 | 0.002073 | 0.001969 | |
| Net Debt To E B I T D A | (1.54) | (2.77) | (1.26) | 0.19 | 5.08 | 5.34 | |
| Current Ratio | 3.63 | 2.95 | 1.09 | 4.56 | 13.81 | 6.97 | |
| Tangible Book Value Per Share | 0.0515 | 0.56 | 1.89 | 4.58 | 4.82 | 5.06 | |
| Receivables Turnover | 3.96 | 2.05 | 3.33 | 4.9 | 5.22 | 9.22 | |
| Graham Number | 2.33 | 3.46 | 5.33 | 15.49 | 2.32 | 2.21 | |
| Shareholders Equity Per Share | 0.12 | 0.58 | 1.91 | 4.6 | 4.83 | 5.07 |
Dynavax Technologies Investors Sentiment
The influence of Dynavax Technologies' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Dynavax. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Dynavax Technologies' public news can be used to forecast risks associated with an investment in Dynavax. The trend in average sentiment can be used to explain how an investor holding Dynavax can time the market purely based on public headlines and social activities around Dynavax Technologies. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Dynavax Technologies' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Dynavax Technologies' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Dynavax Technologies' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Dynavax Technologies.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Dynavax Technologies in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Dynavax Technologies' short interest history, or implied volatility extrapolated from Dynavax Technologies options trading.
Pair Trading with Dynavax Technologies
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Dynavax Technologies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dynavax Technologies will appreciate offsetting losses from the drop in the long position's value.Moving together with Dynavax Stock
| 0.74 | VRAX | Virax Biolabs Group Fiscal Year End 12th of June 2024 | PairCorr |
Moving against Dynavax Stock
| 0.57 | LIXT | Lixte Biotechnology Earnings Call This Week | PairCorr |
| 0.49 | INDP | Indaptus Therapeutics Financial Report 9th of May 2024 | PairCorr |
| 0.41 | GBIO | Generation BioCo Financial Report 8th of May 2024 | PairCorr |
The ability to find closely correlated positions to Dynavax Technologies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Dynavax Technologies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Dynavax Technologies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Dynavax Technologies to buy it.
The correlation of Dynavax Technologies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Dynavax Technologies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Dynavax Technologies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Dynavax Technologies can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dynavax Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. For more information on how to buy Dynavax Stock please use our How to Invest in Dynavax Technologies guide.Note that the Dynavax Technologies information on this page should be used as a complementary analysis to other Dynavax Technologies' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Complementary Tools for Dynavax Stock analysis
When running Dynavax Technologies' price analysis, check to measure Dynavax Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dynavax Technologies is operating at the current time. Most of Dynavax Technologies' value examination focuses on studying past and present price action to predict the probability of Dynavax Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dynavax Technologies' price. Additionally, you may evaluate how the addition of Dynavax Technologies to your portfolios can decrease your overall portfolio volatility.
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |
Is Dynavax Technologies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dynavax Technologies. If investors know Dynavax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dynavax Technologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.77) | Earnings Share (0.05) | Revenue Per Share 1.804 | Quarterly Revenue Growth (0.70) | Return On Assets (0.02) |
The market value of Dynavax Technologies is measured differently than its book value, which is the value of Dynavax that is recorded on the company's balance sheet. Investors also form their own opinion of Dynavax Technologies' value that differs from its market value or its book value, called intrinsic value, which is Dynavax Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dynavax Technologies' market value can be influenced by many factors that don't directly affect Dynavax Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dynavax Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Dynavax Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dynavax Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.